Literature DB >> 24729284

Variants of 11β-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 in Chinese obese adolescents.

Li Li Ruan1, Jun Xu, Chun Lin Wang, Chao Chun Zou.   

Abstract

OBJECTIVE: To investigate the relationship between 11β-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 and obesity in Chinese children.
METHODS: A total of 400 obese and 200 healthy adolescents were enrolled as obese and control groups. Seven SNPs in HSD11B1 (rs4393158, rs2235543, rs10082248, rs10863782, rs2236903, rs2298930, rs4545339) and four variants in HSD11B2 gene (rs28934592, rs28934591, rs28934594 and rs28934593) were measured by automated platform MassArray.
RESULTS: The rs28934592 in HSD11B2 and rs10863782 in HSD11B1 were excluded as false positive or HWE P < 0.05. Moreover, one allele type was found in the other three locations of HSD11B2. The minor allele frequency of rs2235543 and rs10082248 was higher in patients than that in controls (P = 0.045, P = 0.041, respectively). The rs10082248, rs2298930 and rs4545339 were associated with the risk of obesity in the recessive model (P < 0.05, respectively). Moreover, the total cholesterol in patients with GG or AG genotype was significantly higher than that in patients with AA genotype in rs10082248. The rs4393158 was associated with the hypertension in log-additive model test (P = 0.037), and glucose abnormal and hypercholesteremia in dominant model test (P < 0.05, respectively), while the rs2235543 was associated with hypercholesteremia in overdominant model test (P = 0.017).
CONCLUSIONS: The polymorphism of HSD11B1 may be a cause of childhood obesity, or even associated with the complication of childhood obesity. However, variants of HSD11B2 may be not a cause of obesity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24729284     DOI: 10.1007/s40618-014-0075-8

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure.

Authors:  Matthew A Bailey; Eilidh Craigie; Dawn E W Livingstone; Yuri V Kotelevtsev; Emad A S Al-Dujaili; Christopher J Kenyon; John J Mullins
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

2.  Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense/frameshift mutations.

Authors:  Kei Kamide; Yoshihiro Kokubo; Hironori Hanada; Junko Nagura; Jin Yang; Shin Takiuchi; Chihiro Tanaka; Mariko Banno; Yoshikazu Miwa; Masayoshi Yoshii; Tetsutaro Matayoshi; Hisayo Yasuda; Takeshi Horio; Akira Okayama; Hitonobu Tomoike; Yuhei Kawano; Toshiyuki Miyata
Journal:  Hypertens Res       Date:  2006-04       Impact factor: 3.872

3.  Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method.

Authors:  Claudia A Staab; Jochen P Stegk; Sierk Haenisch; Elisabeth Neiss; Katrin Köbsch; Bettina Ebert; Ingolf Cascorbi; Edmund Maser
Journal:  Chem Biol Interact       Date:  2011-01-06       Impact factor: 5.192

Review 4.  Glucocorticoid programming.

Authors:  Jonathan R Seckl; Michael J Meaney
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

5.  11beta-hydroxysteroid dehydrogenase type 1 of the subcutaneous adipose tissue is dysregulated but not associated with metabolic disorders in adults born small for gestational age.

Authors:  T Meas; E Carreira; Y Wang; M Rauh; C Poitou; K Clément; J Dötsch; C Lévy-Marchal
Journal:  J Clin Endocrinol Metab       Date:  2010-06-02       Impact factor: 5.958

6.  Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levels.

Authors:  Elise L V Malavasi; Val Kelly; Nikita Nath; Alessandra Gambineri; Rachel S Dakin; Uberto Pagotto; Renato Pasquali; Brian R Walker; Karen E Chapman
Journal:  Endocrinology       Date:  2009-11-24       Impact factor: 4.736

7.  Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.

Authors:  A Li; R Tedde; Z S Krozowski; A Pala; K X Li; C H Shackleton; F Mantero; M Palermo; P M Stewart
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

Review 8.  Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.

Authors:  Jonathan R Seckl; Megan C Holmes
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-06

9.  Apparent mineralocorticoid excess syndrome in a Brazilian boy caused by the homozygous missense mutation p.R186C in the HSD11B2 gene.

Authors:  Fernanda Borchers Coeli; Lúcio Fábio Caldas Ferraz; Sofia H V de Lemos-Marini; Sumara Zuanazi Pinto Rigatto; Vera Maria Santoro Belangero; Maricilda Palandi de-Mello
Journal:  Arq Bras Endocrinol Metabol       Date:  2008-11

10.  Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.

Authors:  Heather Spencer Feigelson; Lauren R Teras; W Ryan Diver; Weining Tang; Alpa V Patel; Victoria L Stevens; Eugenia E Calle; Michael J Thun; Mark Bouzyk
Journal:  Breast Cancer Res       Date:  2008-07-08       Impact factor: 6.466

View more
  3 in total

Review 1.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

2.  Interaction of HSD11B1 and H6PD polymorphisms in subjects with type 2 diabetes are protective factors against obesity: a cross-sectional study.

Authors:  Marcio F Chedid; Filipe V do Nascimento; Fernanda S de Oliveira; Bianca M de Souza; Cleber R P Kruel; Richard R Gurski; Luis H Canani; Daisy Crispim; Fernando Gerchman
Journal:  Diabetol Metab Syndr       Date:  2019-09-23       Impact factor: 3.320

Review 3.  Neuroendocrinological and Epigenetic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome.

Authors:  Erwin Lemche; Oleg S Chaban; Alexandra V Lemche
Journal:  Front Neurosci       Date:  2016-04-14       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.